Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer

NCT02772107 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small Cell Lung Cancer

Interventions

DRUG: Temozolomide
DRUG: first-line chemotherapy
RADIATION: Prophylactic cranial irradiation
RADIATION: thoracic radiotherapy

Sponsor

Chinese PLA General Hospital